Click here for Sutent® (sunitinib malate) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
The recommended starting dose is 50mg capsule taken orally once daily on a 4 weeks on/ 2 weeks off dosing schedule1.
Treatment with SUTENT should be continued if the patient is deriving clinical benefit from therapy.
SUTENT is for oral administration. It may be taken with or without food. If a dose is missed, the patient should not be given an additional dose. The patient should take the usual prescribed dose on the following day.1
Recommended Starting Dose |
50 mg |
---|---|
1st Dose Reduction |
37.5 mg |
2nd Dose Reduction |
25 mg |
3rd Dose Reduction |
12.5 mg |
Recommended Starting Dose |
|
---|---|
1st Dose Reduction |
37.5 mg |
2nd Dose Reduction |
25 mg |
3rd Dose Reduction |
12.5 mg |
For GIST and mRCC, dose modifications in 12.5 mg steps may be applied based on individual safety and tolerability. Daily dose should not exceed 75 mg nor be decreased below 25 mg.
For pNET, the recommended dose of Sutent is 37.5 mg taken orally once daily without a scheduled rest period, dose modifications in 12.5mg steps may be applied base on individual safety and tolerability.
SUTENT Summary of Product Characteristics
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020
No